CellCentric
- Partner Level
- Website
- Visit Site
Overview
CellCentric is a clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. For more information, visit cellcentric.com.
Patient Support
